INFINITY PHARMACEUTICALS INC - COM (INFI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2024

Type / Class
Equity / COM
Symbol
INFI
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$15 0
2023 Q4 5,700 $15 -$2,890 $0.00 3
2023 Q3 181,168 $2,899 -$4,225,245 $0.02 2
2023 Q2 20,095,444 $4,229,706 +$182,756 $0.21 43
2023 Q1 19,347,718 $3,095,731 -$3,168,550 $0.16 50
2022 Q4 25,059,335 $13,907,180 -$3,611,797 $0.56 62
2022 Q3 30,892,429 $36,760,969 +$1,322,192 $1.19 67
2022 Q2 30,015,116 $18,972,934 -$6,656,943 $0.63 65
2022 Q1 38,944,655 $44,311,697 -$4,588,303 $1.14 85
2021 Q4 41,701,371 $93,820,750 -$15,201,648 $2.25 93
2021 Q3 46,912,739 $160,465,365 +$13,526,842 $3.42 100
2021 Q2 43,785,369 $130,926,079 +$4,539,490 $2.99 93
2021 Q1 41,881,974 $135,876,928 +$34,847,365 $3.23 80
2020 Q4 32,515,039 $68,930,002 +$4,472,577 $2.12 50
2020 Q3 27,437,791 $32,104,047 -$400,127 $1.17 41
2020 Q2 27,793,384 $25,143,047 -$121,885 $0.90 44
2020 Q1 27,920,805 $23,391,378 -$338,116 $0.84 46
2019 Q4 28,341,314 $27,222,068 -$1,567,255 $0.96 45
2019 Q3 29,332,367 $30,215,301 -$2,309,183 $1.03 44
2019 Q2 30,670,098 $55,171,526 -$420,457 $1.80 50
2019 Q1 30,924,099 $58,132,549 +$596,728 $1.88 58
2018 Q4 30,771,922 $36,332,345 -$2,099,186 $1.18 61
2018 Q3 29,553,720 $79,951,791 +$4,767,807 $2.71 58
2018 Q2 28,013,376 $53,508,457 -$1,957,508 $1.91 59
2018 Q1 28,365,188 $59,565,613 +$5,696,862 $2.10 62
2017 Q4 25,701,870 $52,178,593 -$1,139,961 $2.03 58
2017 Q3 27,549,975 $36,614,334 -$9,434,761 $1.33 57
2017 Q2 34,237,919 $53,742,476 -$12,205,553 $1.57 70
2017 Q1 38,587,852 $124,627,696 +$15,594,235 $3.23 77
2016 Q4 38,559,504 $52,053,058 -$2,053,043 $1.35 91
2016 Q3 39,662,629 $61,867,597 -$681,730 $1.56 94
2016 Q2 40,506,688 $53,876,886 -$27,714,800 $1.33 104
2016 Q1 46,010,469 $242,442,000 -$22,562,261 $5.27 114
2015 Q4 49,650,246 $389,738,158 -$23,537,595 $7.85 115
2015 Q3 52,267,721 $441,635,548 +$12,455,598 $8.45 129
2015 Q2 50,518,366 $553,155,689 +$7,440,407 $10.95 135
2015 Q1 49,360,495 $690,255,564 +$32,961,352 $13.98 138
2014 Q4 46,125,421 $779,033,473 +$20,589,018 $16.89 141
2014 Q3 45,168,309 $606,022,346 -$19,006,942 $13.42 115
2014 Q2 46,609,050 $593,621,782 -$56,876,123 $12.74 96
2014 Q1 47,863,022 $568,746,667 +$21,860,705 $11.89 96